Abstract There are two broad-based categories of cementless femoral component designs: proximally porouscoated and fully porous-coated. While both have been widely used, there remains debate regarding differences in clinical outcome scores, relative incidence of thigh pain, and development of stress shielding. We investigated these variables in a multicenter prospective randomized blinded clinical trial of 388 patients from three centers: 198 patients had a proximally porous-coated tapered cementless femoral component and 190 patients had a fully porous-coated cementless femoral component. A minimum followup of 2 years (mean, 6.7 years; range, 2.0-8.65 years) was available in 367 of the 388 patients (95%).
Introduction
There are a large number of cementless implants on the global market from multiple implant manufacturers. In general, the press-fit designs fall into two categories: fully porous-coated cylindrical stems that achieve primarily distal fixation and proximally porous-coated tapered stems that achieve primarily proximal fixation. Both designs have multiple publications supporting excellent clinical results with reproducible mid-to long-term followup. While the clinical track records of both stem designs appear The institution of one or more of the authors has received funding from Physicians Services Inc (SJM, JSG, RWM, RBB, CHR), Smith and Nephew Inc, Memphis, TN (SR, ERB, RLB), and DePuy Inc, Warsaw, IN (SR, ERB, RLB). One or more of the authors certifies that he (RBB, CHR, RLB) has or may receive payments or benefits from a commercial entity related to this work. Each author certifies that his or her institution has approved the human protocol for this investigation that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained. This work was performed at London Health Sciences Centre, Tulane University Medical Center, University of Alabama at Birmingham Orthopaedics, and University of Manitoba Joint Replacement Group. equivalent to date, proponents of proximally coated stems argue fully coated stems have a greater incidence of thigh pain and femoral stress shielding.
The reported incidence of thigh pain after THA with a fully coated femoral component varies between 3% and 20% [7, 13, 27] . While many surgeons presume proximally coated stems, or cemented stems, have a lower incidence of thigh pain than fully coated stems, this remains controversial [1, 2, 17, 25, 28, 30, 38] . Most authors recognize the reported incidence of thigh pain will be influenced by the way a patient is asked about its presence, a point best controlled with a prospective randomized blinded clinical trial.
Femoral bone loss or resorption, so-called stress shielding, around well-fixed femoral components is thought to occur around most, if not all, stem designs [12, 32, 34, 38] . This phenomenon is reportedly exacerbated with fully coated stems [12, 15, 18] . While stress shielding is seen radiographically, its clinical relevance remains to be determined [6, 16, 22] . Engh et al. [16] have demonstrated, while stress shielding did occur in a cohort of the fully porous-coated stems they evaluated, this did not result in specific clinical complications. At the same time, theoretically this bone loss could make a future revision more challenging, although that has not been demonstrated in the literature. Potential complications have also included greater and lesser trochanteric avulsion fractures [33] . Multiple factors have been implicated in the potential to develop stress shielding, including implant design variables, extent of porous coating, stem material, stem stiffness, stem geometry, and method of component fixation.
In a prospective randomized blinded clinical trial, we therefore compared a fully porous-coated femoral component to a proximally porous-coated component to examine differences in (1) clinical scores (WOMAC, SF-12, Harris hip score [HHS], UCLA activity), (2) incidence of thigh pain, and (3) development of stress shielding (as determined by dual-energy xray absorptiometry [DEXA]).
Patients and Methods
Between January 2000 and December 2003, we enrolled 388 patients in this randomized, controlled trial at three institutions: 194 patients at the London Health Sciences Centre (London, Ontario, Canada), 119 patients at Tulane University Medical Center (New Orleans, LA), and 75 patients at the Concordia Hospital (Winnipeg, Manitoba, Canada). We included patients with degenerative disease of the hip undergoing primary THA with either Charnley A or B classification, Dorr A or B femoral morphology as determined by the enrolling surgeon, and between 40 and 75 years of age. We excluded patients with preexisting bone disease including rheumatoid arthritis and avascular necrosis, systemic conditions affecting bone density, and/or a contralateral revision or poorly functioning THA.
We performed a sample size calculation based on detecting a difference in the incidences of postoperative thigh pain between the two study groups, assuming an overall alpha error (two-sided) of 5% with a statistical power of 80% (beta error = 0.20). We assumed the incidence of thigh pain in the Prodigy TM group would be 25% compared to 10% in the Synergy TM group at 2 years' followup. With these assumptions, approximately 97 patients per study group were needed. Allowing for errors in the thigh pain incidence predictions and for withdrawals and losses to followup, we assumed at least 130 patients were needed in each study group. After agreeing to be enrolled in this study, patients were randomly assigned to receive either a proximally porous-coated femoral implant (n = 198) or a fully porous-coated femoral implant (n = 190). There were no differences in the patient demographic parameters between groups ( Patients and the research personnel including the clinical study nurse at each site that oversaw enrollment into the study and all subsequent clinic visits, including the collection of clinical data, were blinded as to component type. All patients were seen and evaluated preoperatively and at 6 weeks, 3 months, 6 months, 1 year, and 2 years postoperatively. Preoperatively and at every postoperative visit, the HHS [19] , WOMAC score [3, 4] , SF-12 score [37] , and UCLA activity ratings score [39] were obtained. To examine the potential differences in thigh pain between stems, a protocol was developed to create a standardized method of assessing the site, frequency, and severity of thigh pain in each patient. This was performed at each followup visit in which the patients completed a brief, selfadministered questionnaire that included specific questions regarding the frequency of thigh pain (daily, weekly, monthly, less frequent), a diagram to document its proximal location, and a 100-mm visual analog scale (from 0-100) for the assessment of its severity.
Numerous authors have commented on the need for, and the value of, a more accurate measure of periprosthetic bone density (PBD) [5, 14, 29, 31] . At the time of the study's inception, the use of DEXA scans to evaluate PBD was a relatively recent application allowing for more accurate and precise measurements of PBD [13, 20, 24, 35, 36] . To observe the potential differences in changes with PBD between stems, we performed DEXA scanning in a subcohort of 72 of the 367 patients (20%) at two of the three sites (London and Winnipeg). Scans were obtained preoperatively for both hips and the spine and for the operated hip and spine at 6, 12, and 24 months postoperatively. In addition, a DEXA scan was performed of the operated hip at 2 weeks to serve as the early postoperative baseline measure. Density changes on the operative limb were interpreted in terms of immediate changes, changes seen over time within a femoral component type, and changes seen between femoral components at any given time interval. One surgeon performed a posterolateral approach and all others performed an anterolateral approach. While the femoral preparation itself between the two stem types is obviously different, it was performed in a standardized fashion by all sites and surgeons. The Synergy TM stem is a taper design and is prepared with proximal reaming and rasping, but no distal reaming. The Prodigy TM stem preparation includes distal cylindrical reaming, as well as proximal rasping. The bone density changes replicated these preparation differences. The two centers that took part in the DEXA analysis utilized different equipment (Hologic TM QDR4500 [Hologic, Inc, Bedford, MA] and GE Lunar Prodigy [GE Corp, Fairfield, CN]); however, the majority of the DEXA analysis, 61 of the 72 cases, was performed on the Hologic TM system. This technique was chosen based on the fact that bone density cannot be accurately derived from standard radiographs due to variability in multiple factors (eg, target distance, film lot exposure) [26] . Briefly, the device uses a narrowly collimated xray beam filtered to allow the emission of two energies (38 and 70 keV). These two energies attenuate differentially in soft tissue and bone, allowing for the calculation of bone mineral density in both grams and grams per square centimeter, with only a small radiation dose to the patient (\ 5 mrem/scan). PBDs were calculated using commercial software from standardized anteroposterior DEXA scans at the appropriate intervals. Preoperatively, the PBDs were measured on one standard area from both hips and the spine for each patient. In the hip region, this area was defined as an area of 17.7 9 5 pixels (equivalent to 21 9 6 mm on the patient), with the distal end of the sample area being at the margin of the lesser trochanter, proceeding proximally. The lower lumbar spine was measured with DEXA to allow a measurement of normal bone loss occurring in each patient. PBD was calculated at each time for each Gruen zone based on the anteroposterior DEXA scans. Sample size calculation was performed to determine the number of patients that would require DEXA analysis. Once again, an overall alpha error (two-sided) of 5% and an 80% power (beta error = 0.20) was used. By assuming a coefficient of a variation in the cobalt stem of 25% and the titanium stem would demonstrate a 17% higher bone mineral density, a sample size of 34 patients per group was calculated to detect a 17% difference in PBD between the two stems. A total of 72 patients had DEXA analysis performed: 61 patients in London and 11 patients in Winnipeg. The lumbar spine DEXA evaluations were performed to act as a control and document any systematic changes over time of bone mineral density. No changes over time in either treatment group were observed (Table 2) . Patients over the 2-year interval maintained their bone mass. Therefore, specific changes seen after component placement were assumed to be secondary to the surgery rather than due to any generalized bone loss. The contralateral femur was also evaluated at each of the time intervals to demonstrate any effect on lower extremity bone mass changes that may have occurred secondary to patients having undergone a THA procedure; similar to the findings in the lumbar spine, patients over this time interval had similar bone mineral density values preoperatively and at the last postoperative evaluation ( Table 2 ). The baseline bone density evaluation at 2 weeks was compared with each subsequent time interval, in each of the Gruen zones, for both stem types to evaluate for progressive bone loss, or stress shielding. Absolute bone density differences between the two stem designs, in each of the Gruen zones, at each time interval, were also evaluated. It is important to understand this does not take into account the differing baseline values demonstrated at the 2-week baseline evaluation. An alternate, and perhaps more clinically relevant, way to evaluate the bone density changes between implants is to assess the percentage of bone loss seen in each of the Gruen zones between the immediate postoperative and 2-year postoperative assessments and this was evaluated. Additionally, the relative effect of baseline bone mineral density on subsequent risk for stress shielding was assessed. Patients were divided into three groups based on baseline DEXA values: Group 1 representing 20th percentile or lower, Group 2 representing 20th to 80th percentile, and Group 3 representing 80th percentile or higher. Lastly, the relative effect of stem size and bone loss was evaluated. Both the Synergy TM and Prodigy TM stem lines were divided into smallest, middle, and largest stems to evaluate for patterns of bone loss related to stem size.
Upon completion of all 2-year patient followups, summary statistics were compiled. Stem group demographics were compared to ensure they were similar. Continuous demographic variables (age, height, weight, body mass index) were determined to be parametric with the Kolmogorov-Smirnov test and compared between the two stem groups using Student's t test. Differences in gender were determined using cross-tabulation with Fisher's exact test. Clinical outcome measures (WOMAC, SF-12, HHS, UCLA activity) and bone density were compared between stem groups with Student's t test after determining the data were normally distributed with Kolmogorov-Smirnov test. The incidence and frequency of thigh pain were compared between study groups using cross-tabulation with the Mantel Haenzel summary chi square statistic. Severity of thigh pain was compared between study groups and time periods using repeated-measures analysis of variance. Changes in PBD between study groups and each Gruen zone were also evaluated using repeated-measures analysis of variance. All statistics were performed with SPSS 1 Version 16 (SPSS Inc, Chicago, IL).
Results
We observed no difference in the HHS, WOMAC, SF-12, or UCLA activity scores at the preoperative or 2-year postoperative visit between the implant groups ( Table 3 ).
There was a high incidence of preoperative thigh pain related to the underlying diagnosis of osteoarthritis, but no differences between groups (71% in the Synergy TM group and 69% in the Prodigy TM group). At 6 months, 1 year (11% Synergy TM and 14% Prodigy TM ), and 2 years (9% Synergy TM and 6% Prodigy TM ), the incidence of thigh pain was similar in the two groups (Table 4) . For those who reported thigh pain, the severity was similar in the two groups at all followup periods (Table 4 ). In patients who reported thigh pain, most reported experiencing pain daily rather than weekly, monthly, or less frequently; this finding was similar (p [ 0.102) in the two cohorts.
The 2-week bone density changes reflected the differences in canal preparation for the Prodigy TM stem, with Table 6 ). In terms of the relative effect of baseline bone mineral density on subsequent risk for stress shielding, the same pattern was seen with both stem types in Gruen Zones 1 and 3: patients with greater baseline bone mineral density (Group 3 representing 80th percentile or higher) were at a greater risk of having a greater percentage of bone loss over time for both the Synergy TM stem cohort (Table 7 ) and the Prodigy TM stem cohort (Table 8 ). The Prodigy TM stem showed no differences in percentage of bone loss over time with different stem sizes (Table 9) ; however, the Synergy TM stem demonstrated a greater percentage (p = 0.042) of bone loss over time in Gruen Zone 7 with the larger stem diameters (Table 10) .
Discussion
We performed a multicenter prospective randomized clinical trial comparing two distinct femoral component designs: a fully porous-coated cobalt-chrome stem and a proximally porous-coated titanium stem. While both stems have had excellent clinical track records, questions remain regarding each stem design and the relative incidence of thigh pain and postoperative bone density changes. We therefore evaluated multiple validated outcome measures (WOMAC, SF-12, HHS, UCLA activity scores), the incidence and severity of thigh pain, and the postoperative DEXA scan changes to find any differences between stem designs.
There are several limitations to this prospective randomized clinical trial. First, the followup period at 2 years is clearly an early postoperative period and demonstrates early trends that will not necessarily be seen with longerterm evaluation. Second, the DEXA scans were only performed in a subcohort of 72 patients and are only adequately powered to demonstrate a 17% difference in bone density between stem designs. Clinically relevant bone density changes have not been clearly established in the literature; however, certainly one could argue a larger sample size would have demonstrated more significant changes between the stems if the trends remained the same. Additionally, because of the smaller sample size in the DEXA cohort, subgroup analysis of the effects of stem size and preoperative bone density to subsequent postoperative changes is underpowered to demonstrate significant differences. While the DEXA scans provided objective data that allowed comparison between two femoral components, these scans are a challenge to perform as part of a routine followup evaluation. Patients require additional imaging over plain radiographs, which increases time and costs of followup. Patients require a baseline DEXA evaluation early in their postoperative course to allow comparison to late imaging and DEXA is not routinely available in all radiology departments. Unfortunately, therefore, DEXA scans cannot be used as a practical routine postoperative evaluative tool. Third, while the majority of DEXA scans were performed at one center with one type of DEXA scanner (Hologic TM QDR4500), the second site employed a different type of scanner (GE Lunar Prodigy), which can introduce a potential evaluation error [21, 23] . However, we evaluated changes in bone density from baseline and each patient served as his/her own control in this study design. The results discussed are patterns of change from a baseline, rather than attempting to discuss absolute density values, which would be challenging with two types of DEXA scanners used in this trial. Both femoral components provided reproducible results in terms of clinical outcome scores. We observed no differences in WOMAC, SF-12, HHS, or UCLA scores at any time interval between the cohorts. This finding was expected, as both stems have been used widely in clinical practice with good clinical track records [7] [8] [9] [10] .
The overall incidence of thigh pain at 2 years was 9% for the Synergy TM stem and 6% for the Prodigy TM stem. While this may be considered higher than previously reported [7, 9] for these stems (Table 11) , it must be emphasized, in this study, the data were prospectively collected and patients were asked repeatedly and directly about the presence of thigh pain.
The DEXA scan evaluations demonstrated two distinct patterns of bone mineral density changes: immediate and progressive. The immediate 2-week postoperative scans demonstrated substantial differences between the stems that we believe represent changes secondary to different surgical femoral preparation techniques and have not seen discussed previously in the literature. Preparation of the femur to accept the Prodigy TM stem includes distal cylindrical reaming and proximal rasping. To place the In this prospective randomized multicenter blinded clinical trial comparing a proximally porous-coated titanium taper stem design to a fully porous-coated cobaltchrome stem design, we observed no differences in clinical outcome scores and incidence of thigh pain. Progressive femoral bone loss was seen with both component designs. Perhaps, over a longer followup period, the progression of stress shielding will vary with stem type, but that remains to be proven and would not follow previously published reports [11, 12] showing most changes occur within 2 years. 
